Can Targeted Therapy Be Combined — with Chemotherapy or Radiation?

No. The combination helps for some cancers and makes things worse for others. In cancers where a targeted therapy works well because of a specific biomarker, adding chemotherapy can reduce its effectiveness or increase toxicity without improving outcomes. In other cancers, the combination is the standard of care because trials showed it works. The guide here is the evidence for your specific cancer type and drug — not the idea that more treatment equals better treatment.

Usually because the evidence shows targeted therapy works better on its own for your biomarker profile. For cancers driven by a specific mutation, targeted therapy alone is often more effective and better tolerated than any combination. Being told you do not need chemotherapy alongside your targeted therapy is not a sign your cancer is less serious — it is a sign your treatment plan is matched to how your tumour behaves. Ask your oncologist to explain specifically why the combination was not chosen.

Usually yes — you may experience side effects from both treatments rather than one. Which ones appear, and how severe they are, depends on the specific drugs involved. Your team monitors you more closely during combination treatment and gives you written guidance on what to report. Do not assume a new symptom is just expected. Some side effects from combinations need prompt attention, so call your team rather than waiting for your next scheduled appointment.

Ask which guideline the recommendation follows — NCCN, ASCO, ESMO, or ICMR. A combination that appears in current guidelines for your cancer type, stage, and biomarker result is the clearest sign it is appropriate. If you want further confidence, ask for a second opinion on the treatment plan. Most oncologists encourage this, and seeking one does not delay treatment in any meaningful way.

That depends entirely on the specific drugs involved and your team's instructions. Some oral targeted therapies are taken continuously through chemotherapy cycles. Others are paused on chemotherapy days or in the days surrounding them. Never adjust the timing yourself based on general advice. Follow the schedule your team gives you in writing, and call them before changing anything — including skipping a dose because you felt unwell that day.

That depends on why the chemotherapy was stopped and what your oncologist decides from there. In some treatment plans, the targeted therapy continues alone after chemotherapy ends. In others, a change to one part of the plan requires reviewing the whole plan. Your oncologist will discuss this with you if it happens — it is a clinical decision that depends on how your cancer has responded and what your body has tolerated.

Yes. Both chemotherapy and targeted therapy are administered as day care at CION centres, and the two are coordinated within the same treatment plan where guidelines support the combination. Response-assessment scans such as PET-CT are coordinated with partner imaging centres. CION does not provide CAR-T or cell therapy. If your treatment plan includes radiation, your oncologist will coordinate with the relevant radiation oncology team.

The duration depends on your cancer type, stage, and the drugs involved. Adding chemotherapy does not necessarily make treatment longer. In some plans, chemotherapy runs for a defined number of cycles and the targeted therapy then continues alone. In others, both are given throughout. Ask your oncologist for a timeline at the start of treatment — and if you did not receive one, it is reasonable to ask for it at your next appointment.